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Abstract. To gain insight into the mechanisms in- 
volved in the formation of maternally  stored mRNPs 
during Xenopus laevis development, we searched for 
soluble cytoplasmic proteins of the oocyte that are 
able to selectively bind mRNAs, using as substrate ra- 
diolabeled mRNA. In vitro mRNP assembly in solu- 
tion was followed by UV-cross-linking and RNase 
digestion,  resulting  in covalent tagging of polypeptides 
by nucleotide transfer.  Five polypeptides of ,,054,  56, 
60, 70, and  100 kD (p54, p56, p60, p70, and pl00) 
have been found to selectively bind mRNA and assem- 
ble into mRNPs.  These polypeptides, which cor- 
respond to previously described native mRNP compo- 
nents,  occur in three different particle classes of 
•4.5S,  ,,o6S, and •15S,  as also determined by their 
reactions with antibodies against p54 and p56. 
Whereas the ,'o4.5S class contains p42, p60, and p70, 
probably each in the form of individual molecules or 
small complexes, the ,x,6S particles appear to con- 
sist only of p54 and p56, which occur in a near- 
stoichiometric ratio suggestive of a heterodimer com- 
plex.  The ,,ol5S  particles contain,  in addition to p54 
and p56, p60 and pl00 and this is the single occurring 
form of RNA-binding pl00.  We have also observed 
changes in the in vitro mRNA binding properties of 
these polypeptides during oogenesis and early em- 
bryonic development, in relation to their phosphoryla- 
tion state and to the activity of an ",,15S particle- 
associated protein kinase,  suggesting that these 
proteins are involved in the developmental transla- 
tional regulation of maternal mRNAs. 
T 
RANSLATIONAL  regulation  of gene expression has re- 
cently been  accumulating  as  a  primary  regulatory 
mechanism in eukaryotic systems  (Hunt,  1988;  Ko- 
zak, 1988; Brawerman,  1989), with two major categories of 
mechanisms being distinguished:  those affecting mRNA sta- 
bility and those involving specific proteins interfering  with 
the translational  activity of mRNAs.  A classic  example of 
regulation at the translational  level is presented by the mater- 
nal mRNAs in early development.  In certain invertebrates 
and vertebrates, several mRNAs are transcribed and stored 
during oogenesis which are required for, and translated  in, 
blastula and postblastula stages of embryogenesis (Woodland 
et al.,  1979; Lee et al.  1984; Stick and Hausen,  1985). A 
characteristic of these stored maternal  mRNAs is their im- 
mediate and effective translational  repression during oogene- 
sis and  their  sharply  regulated activation  at defined  time 
points after fertilization  (for review see Davidson,  1986). 
The probably best studied vertebrate in this  respect is the 
African  clawed  toad,  Xenopus laevis (Woodland,  1974; 
Richter,  1987), whose oocytes accumulate and store transla- 
tionally blocked ("masked") maternal  mRNAs that are how- 
ever translatable in vitro,  indicating  that  translation  is not 
controlled by alterations  of the mRNA (e.g., Ballantine  et 
al., 1979; Davidson,  1986; Wolin et al.,  1987). It is widely 
assumed  that  proteins  associated  with  these  maternal 
mRNAs mediate the translational  repression (Spirin,  1966; 
Richter,  1987; Kandror and Stepanov, 1988) although the de- 
tails  of the molecular mechanisms  of maternal  mRNP as- 
sembly and mobilization  have not been elucidated. 
In Xenopus oocytes, major protein components of mRNP 
particles have been identified (Darnbourgh and Ford, 1981) 
and  in part characterized  with regard to their capacity to 
bind, on filters, radioiodinated  mRNA (Richter and Smith, 
1983; Dearsly et al., 1985; Kick et al., 1987; Richter,  1987). 
It has also been reported that when proteins released by high 
salt buffer from such mRNP are allowed to bind to rabbit 
globin mRNA, they form complexes translationally  inactive 
upon microinjection  into oocytes (Richter and Smith,  1984), 
and similar results have been obtained with in vitro transla- 
tion systems (Kick et al., 1987). This has been taken to indi- 
cate that some mRNA-associated proteins mediate transla- 
tional  repression of maternal  mRNAs. 
To elucidate the mechanisms  of maternal  mRNA storage 
as mRNP we have identified,  in oocytes and early embryos, 
the soluble cytoplasmic proteins that can bind mRNAs and 
assemble mRNPs in vitro from radiolabeled mRNA, using 
fixation of the assembled complexes by UV-cross-linking and 
tagging by RNase treatment  and nucleotide transfer to poly- 
peptides,  which were then analyzed by gel electrophoresis. 
Using this assay, we have identified three distinct forms of 
soluble mRNA-binding  proteins and particles, and we show 
that their mRNA binding is influenced by protein phosphory- 
lation. 
©  The Rockefeller University Press, 0021-952519110111111 $2.00 
The Journal of  Cell Biology, Volume 112, Number 1, January 1991 1-11  1 Materials and Methods 
Animals, Oocytes, and Embryos 
Procurement of Xenopus/aev/s adults, in vitro fertilization of eggs, handling 
of embryos, and dissection of oocytes were as described (Benavente etal., 
1985).  Oocytes  were staged according to their diameter (Dumont, 1972) 
and embryos according to the Normal Table (Nieuwkoop  and Faber,  1967). 
Preparation of  Radiolabeled mRNA and 
Protein Extracts 
mRNA transcribed from the Xenopus/aev/s lamin LI eDNA (Krohne et al., 
1987) was used in all experiments, although similar results were obtained 
with mRNA  of the nucleolar protein NO38  (Schmidt-Zachman etal., 
1987), and the histone binding proteins N1 and nucleoplasm (Kleinschmidt 
et ai.,  1986; Dingwall etal.,  1987). The transcription reaction (Melton et 
ai.,  1984) was modified,  being carried out in a final volume ofS0/~1 with 
200 t~Ci c~32p-CTP (800 Ci/mmol; New  England Nuclear,  Du Pont de 
Nemours, Bad Homburg, FRG), 0.5 mM ATE GTP,  and 5-bromo UTP 
(5 br-UTP; I Pharrna-Waldhof GmbH, Diisseldorf, FRG), and 24 nM CTP. 
After ethanol precipitation, the lamin LI mRNA (Krohne et al., 1987) was 
polyadenylated  (20 fd reaction volume)  with 1 U Escherichia coli PolyA 
polymerase  according to the  supplier's  protocol  (Pbarmaeia,  Freiburg, 
FRG) for 10 min at 37°C, purified by extraction of proteins with phenol and 
chloroform and precipitated with ethanol, dissolved in sterile water (treated 
with 0.1% DEP; diethylpyrocarbonate), and used within 5 d. For RNA ra- 
diolabeled exclusively during polyadenylation,  one-twentieth  of a nonradio- 
labeled transcription reaction was polyadenylated  with 50/~Ci u32p-ATP 
(800 Ci/mmol; New England Nuclear). 
All  solutions and glassware  were  freed of RNase  contamination by 
sterilization and/or treatment with DEP. S100 extracts were prepared essen- 
tially as described (Dignam et al., 1983) and stored at -70°C. No change 
in mRNA binding was noted with long-term storage (up to 1 yr); however, 
repeated freezing  and thawing  was avoided. 
Stage VI oocytes were dissected in sterile 5:1 medium (83 mM KCI, 17 
mM NaC1, 10 mM Tris-HC1, pH 7.2) containing 0.5 mM PMSE the germi- 
nal vesicles placed on ice, and the ooplasmic material used for preparing 
the  cytoplasmic  low-speed  supernatant (LSS)  fraction:  Ooplasms  were 
homogenized by repeated pipetting through a 200-td pipette tip, followed 
by two rounds of centrifugatinn at 12,000 g for 10 min at 4°C, and the final 
supernatant was taken with minimal lipid.  The final assay volume for the 
nuclei and cytoplasmic fractions was 25 ~1. For sedimentation analyses,  50 
oocytes were dissected, and each fraction was incubated in a final volume 
of 225 pl, and 200 #1 were applied to the glycerol gradient. Glycerol gra- 
dient sedimentation  of RNPs was performed as described by Cummings and 
Sommerville (1988), except in 4.2-ml gradients and in a rotor (SW60; Beck- 
man Instruments Co., Fullerton, CA) at 55,000  rpm for 90 minutes,  and 
200/~! fractions collected with a displacement apparatus linked to a UA-5 
absorbance monitor at 254 nm (ISCO, Lincoln, NE). Normal polyribosome 
preparations were spun in parallel. 
Freshly  prepared  ovary  S100  extract  was  concentrated threefold  by 
vacuum dialysis against buffer D (20 mM Hepes,  pH 7.9, 0.1 M KCI, 0.2 
mM DTT, 0.2 mM EDTA,  1 mM PMSF; Dignarn et al.,  1983), and 500 
/zl (i.e., '~,50 mg protein) was applied to a 13-ml 5-30% glycerol gradient 
in buffer D, centrifuged at 36,000 rpm for 18 h in a rotor (SW40; Beckman 
Instruments), and 400/~1 fractions taken. For reference,  BSA (4.3S), cata- 
lase (11.3S), and thyroglobulin (16.5S) were applied to a parallel gradient. 
Conditions of  mRNA Binding Assay 
The optimal conditions for the protein-mRNA binding assay were empiri- 
cally determined from conditions used in similar assays (Greenberg, 1980; 
Hamm et al.,  1987; Leibold and Munro,  1988).  1.0-2.5  x  106 cpm of 
mRNA was mixed with S100 extract (50 or 100 #g) or other oocyte frac- 
tions, in incubation buffer (2 mM MgCI2,  1 mM DTT,  1 mM ATP, 100 
mM KC1, 2--4 U/tzl RNasin) in a final volume of 10/~1 in microtiterwells, 
incubated for 1 h on ice, and then exposed to 312 nm UV light (filter re- 
moved;  K. Benda, Wiesloeh, FRG) at a minimal distance, for 30 rain on 
ice. When designated,  heparin was added (5 mg/ml final concentration; por- 
cine intestine grade IA; Sigma, Deisenhofen, FRG) before UV exposure. 
The mixture was digested  in 10 mM Tris-HCl (pH 7.5) with 500 U/ml 
1. Abbreviations used in this paper:  5-brUTP, 5-bromoUTP. 
RNase TI and 0.34 mg/ml RNase A (Boehringer,  Mannheim, FRG) for 30 
min at 37°C,  and the proteins were precipitated with 10% TCA,  washed 
with 90% acetone, and separated by SDS-PAGE (10 or 12%). Autoradio- 
graphic ezposum was usually overnight, using an intensifying scaeen and Kodak 
XAR film. In competition experiments bovine liver tRNA (Boehringer)  or 
total ovary RNA were first mixed with the SI00 extract at the final incuba- 
tion conditions.  For experiments  using oocyte fractions, the final salt con- 
centration was  100 mM (83 mM KCI and 13 mM NaCI). 
Protein Isolation, Antibodies,  Immunoblotting, 
and Immunoprecipitation 
Isolation of p54 and p56 during preparation of the homooligomeric 14.5S 
ATPase particle has been documented elsewhere (Peters et ai., 1990). Xeno- 
pus ovaries were homogenized  in buffer A (5:1 medium containing 2 mM 
DTT, 0.2 mM CaC12, 0.5 mM PMSF). The 100,000 g 1-h supernatant was 
subjected to ion exchange chromatography,  and bound proteins were eluted 
by increasing ionic strength in buffer A (60-500 mM KCI). Fractions con- 
taining particles of '~5-20S were pooled, precipitated with ammonium sul- 
fate (80 %), dissolved in 5:1 medium, and analyzed by sucrose gradient cen- 
trifugation (5-30%). The '~6S fraction contained primarily p54 and p56, 
which bound radiolabeled mRNA in the mRNA binding assay. 
The polypeptides  of the '~6S peak were separated  by SDS-PAGE (Fig. 
4, lane/), polypeptide bands containing p56 and p54 were excised, and the 
protein was eluted from the gel and used for immunization of guinea pigs 
as described (Benavente and Krohne, 1986). For immunoblotting, proteins 
were separated  by SDS-PAGE, transferred to nitrocellulose,  and the filter 
blocked with 1% BSA, 0.05% Tween-20 in PBS (137 mM NaC1, 2.7 mM 
KC1, 6.5 mM Na2HPO4, 1.5 mM KH2PO4). This was probed with p54/p56 
antisera at dilution 1:20,000, and immunocomplexes  were detected using 
t25I-labeled protein A and autoradiography. 
For isoelectric focusing  experiments,  five unfertilized  eggs  were  dis- 
rupted in concentrated sample buffer, urea was added to 8 M, and the total 
proteins were separated in the first dimension by isoelectric focusing (O'Far- 
tell,  1975) and then SDS-PAGE (10%). Protein analysis by NEPHGE re- 
quired removal of yolk platelets:  stage II oocytes or unfertilized  eggs were 
homogenized in buffer  D  containing aprotinin (2  /~g/ml) and leupeptin 
(0.5/~g/ml),  and the supernatant from two successive  12,000 g spins for 10 
min each at 4°C was taken. An aliquot equivalent to one oocyte or egg was 
used for NEPHGE; a 10% gel was used for the second dimension (O'Farrell 
etal., 1977). BSA and skeletal muscle actin were added as isoelectric refer- 
ences, and nitrocellulose  filters stained with Ponceau  S (Sigma). 
For immunoprecipitation of'ul5S material, the IgG fraction of p54/p56 
antibodies bound to cyanogen bromide-activated Sepharose  (Pharmacia) 
was used.  Guinea pig antibodies against Xenopus lamin LI were used as 
control. 
For phospholabeling of the 15S protein particle material, 4.5 td of frac- 
tion 18 (Fig.  5) was  incubated with 2 /~Ci "ys2p-ATP (>5,000 Ci/mmol; 
Amersham Buchler, Braunschweig,  FRG) at 10 mM MgC12, 100 mM KCI, 
1 mM DTT for 30 min at 20"C in 10/~1. The sample volume was then in- 
creased to 200/~1 in buffer D containing aprotinin (2/~g/ml) and leupeptin 
(0.5  t~g/ml), and 50-#1 aliquots  immunoprecipitated overnight at 4"C in 
buffer B (0.1% SDS, 0.5%  deoxycholate,  1% NP-40, 20 mM methionine, 
50 mM Tris-HCl (pH 14), 150 mM NaC1, 2 mM EDTA) plus 0.5 mM ATP. 
The Sepharose-antibody complex was washed three times with buffer B, 
and immunoprecipitated polypeptides  dissolved  in concentrated sample 
buffer. 
Phosphatase Treatment and Protein Kinase Assay 
Protein fractions containing 4.5S and 6S or 15S material (7.5 ttl of fractions 
6 and 16, Fig.  5) were incubated with either calf intestinal phosphatase 
(Boehringer; 20 U), or an equal volume of phosphatase dilution buffer (50 
mM Tris-HCl, pH 9.0, 1 mM MgCl2, 0.1 mM ZnCI,  1 mM spermidine) 
for 30 rain at 37°C in the presence of aprotinin and leupeptin.  For lcss exten- 
sive phosphatase treatment, 15S material (4.5 t~l of fraction 18, Fig. 5) was 
incubated with 0, 2, or 10 U in the presence of 1 mM ATP at 20°C for 30 
rain. For protein kinase activity, 5 t~l of 15S rnaterial  (fraction 18, Fig. 5) 
was incubated with 2/~Ci 3,32p-ATP at 10 mM MgC12, 100 mM KCI, 1 mM 
DTT (10/~1 final volume) for 30 rain at 20°C,  in the presence or absence 
of 0.1 mg/ml heparin. For the influence of protein kinase activity on pro- 
tein-mRNA binding, 7.5 #tl of fraction 13 (Fig. 5) was first incubated at ei- 
ther optimal (10 mM MgCI2,  10 mM ATP) or suboptimal (2 mM MgC12, 
1 mM ATP) conditions at 20°C for 30 min and then tested for mRNA bind- 
ing on ice. Heparin (0.1 mg/mi) was added at the beginning or end of the 
20°C incubation period. 
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mRNA are detected by autoradiography after UV-cross-linking  to covalently radiolabel the RNA binding proteins. Proteins of a 100,000 g, 
1-h supernatant fraction (S100) from Xenopus ovary were incubated with radiolabeled mRNA transcribed  from lamin LI cDNA with 
a32p-CTP and 5-brUTP in incubation buffer with 40-500 mM KCl on ice for 1 h. The resulting particles were exposed to 312 nm light 
for 30 min, digested with RNases A and T1, "IV_A  precipitated, and separated by SDS-PAGE. (a and b) Influence of increasing ionic strength 
on the binding of  proteins from ovary S100 extract to nonpolyadenylated mRNA. 100 #g of ovary S100 extract was incubated at increasing 
KCI concentrations (lane 1, 40 mM; lane 2, 100 mM; lane 3, 200 mM; lane 4, 300 mM; lane 5, 400 mM; lane 6, 500 mM) with 2  x 
106 cpm of mRNA for 1 h on ice, without (a) or with (b) addition of heparin (5 mg/ml) before UV-cross-linking. (c and d) Competition 
of protein binding to nonpolyadenylated mRNA was assayed by addition of tRNA (c, lanes 1-5: O, 1.0, 5.0, 10, and 20 mg/ml), poly(A) 
(c, lane 6:20 mg/ml) or total ovary RNA (d, lanes 1-5: O, 0.25, 0.5, 1.0, and 2.0 mg/ml) to 100 #g of S100 extract at 100 mM KC1 incubation 
conditions before adding the radiolabeled mRNA, followed by incubation for 1 h, addition of heparin (5 mg/ml) and UV-cross-linking. 
(e) The influence of polyadenylation on protein-mRNA bind'rag was tested using mRNA having a nonradiolabeled poly(A) tail: increasing 
amounts of total ovary RNA (lanes 1-4: O, 0.25, 0.5, and 1.0 mg/ml) were added to ovary S100 extract (50/~g each) as in d, except that 
heparin was not added. (f) mRNA radiolabeled exclusively  during polyadenylation was used as substrate to determine which proteins could 
be detected as binding directly to the poly(A) tall.  50 ~g of S100 protein extracts from immature or mature ovaries, unfertilized eggs, 
and neurula (stage 15) embryos (lanes 1-4) were assayed under standard conditions, without addition of heparin. The dots in a-e indicate 
polypeptides of 100, 60, 56, 54, and 42 kD (pl00, p60, p56, p54, and IM2), and in f, p60. The proteins were separated on 10% (a-d) 
or 12% (e and f) gels, and the horizontal bars to the right or left indicate the respective relative molecular mass standards for each (97, 
66, 46, and 35 kD). No signal was detected in controls omitting UV exposure or when BSA was substituted for the ovary S100 extract. 
Results 
We initiated our study by examining the protein component 
of native Xenopus laevis maternal mRNP and found a com- 
mon set of proteins associated with mRNPs, thus confirming 
Darnbourgh and Ford (1981) who identified a  set of eight 
polypeptides (16, 22, 50, 52, 56, 59, 75, and 100 kD) in all 
sedimentation classes of poly(A)-rich mRNPs from imma- 
ture ovaries.  Moreover, in other authors' previous studies, 
mAbs  raised  against  the 56-kD polypeptide (Richter and 
Evers,  1984)  recognized 40-60S  mRNPs,  although  some 
nonreactive 56-kD polypeptides were also found in faster 
sedimenting mRNPs. These antibodies were subsequentially 
used to select translationally regulated mRNAs from imma- 
ture oocyte mRNPs (Crawford and Richter, 1987). In agree- 
ment with these data, phosphorylated '~54-, 56-, and 60-kD 
polypeptides have been identified as components of  40-120S 
mRNPs  (Cummings  and  Sommerville,  1988),  whereas in 
the earliest oogenic stages phosphorylated p56 was found 
primarily in 6-18S particles that also had protein kinase ac- 
tivity. Finally, experiments by Swiderski and Richter (1988), 
using microinjection of radiolabeled mRNAs  into oocytes 
that was followed by UV irradiation of the oocyte homoge- 
nate, had shown a set of proteins, including polypeptides of 
56 and 60 kD, bound both translationally competent (globin) 
and stored (G10) mRNAs, in addition to some unique pro- 
teins. On the basis of  these thorough biochemical characteri- 
zations of Xenopus maternal mRNPs, we devised a general 
biochemical assay to detect possible soluble forms of such 
RNA-associating  proteins by assembly of mRNP  in vitro 
from soluble components. 
Detection of Soluble mRNA Binding Proteins 
To identify proteins of oocytes, eggs, and embryos that bind 
mRNA  and assemble into mRNPs,  radiolabeled substrate 
mRNA was incubated with proteins contained in the 100~000 g, 
1-h supernatant ("soluble proteins," "S100 extract"; Dignam 
et al.,  1983), and proteins bound to this mRNA were then 
detected by  radioactive nucleotide transfer upon  covalent 
UV-cross-linking (Greenberg, 1980), RNase digestion, and 
SDS-PAGE. For this assay, mRNA was labeled during tran- 
scription  in  vitro  from  Xenopus  laevis  lamin  LI  cDNA 
(Krohne et  al.,  1987)  by  incorporation of 5-brUTP  and 
o~32p-CTP, and, when desired, was also polyadenylated using 
E.  coli poly(A) polymerase.  Identical results  (see below) 
were obtained when other mRNAs were tested. Incorpora- 
tion of 5-brUTP enhanced the cross-linking at least 50-fold 
over nonsubstituted substrate mRNA (not shown), facilitat- 
ing the sensitivity of the mRNA binding assay. Pretreatment 
of  the extracts with micrococcal nuclease had no effect on the 
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of mRNA binding proteins. The 
germinal  vesicle was  removed 
from stage VI oocytes and a cyto- 
plasmic  low-speed  supernatant 
(LSS)  prepared. The  substrate 
mRNA  was  radiolabeled only 
during in vitro transcription with 
inclusion of 7-methyl-GTP cap 
analogue. Nuclei (lanes 1 and 3) 
or LSS (lanes 2 and 4) from two 
oocytes were incubated with ei- 
ther mRNA having a nonradio- 
labeled poly(A) tail (lanes 1 and 
2) or nonpolyadanylated  mRNA 
(lanes 3 and 4) undtr standard 
conditions, immediately following their isolation in 5:1 medium. 
The dots indicate pl00, p95, p90, p60, p56, p54, and p42 (10% gel). 
In Fig. 2 and 3, capped mRNA was used, although inclusion of cap 
analogue  had no effect  on mRNA binding of soluble ovary  proteins. 
was added (Fig.  1 e):  in this case, it did not diminish p60 
binding but completely abolished the binding of p56  and 
p54, even at concentrations that did not affect their binding 
to non-polyadenylated  mRNA (compare Fig. 1 d, lane 3, and 
e, lane 2). To investigate which proteins bind directly to the 
poly(A) tail,  substrate mRNA radiolabeled solely during 
polyadenylation, i.e., in the poly(A) tail, was used (Fig.  1 
f):  significant labeling was found only in association with 
p60  (lanes  1-4).  Immunoprecipitation of protein radiola- 
beled after the binding assay with antibodies provided by 
John SommerviUe (St. Andrews, Scotland; data not shown) 
protein binding detected, indicating that any RNA present 
had no effect on the protein binding studied. 
To identify the proteins binding to the substrate nfl~A 
and the forces involved, various conditions were tested. As 
seen in Figs.  1 and 2, a series of polypeptides (42, 54, 56, 
60, 70, 75, 90, 95, and 100 kD) was transfer-radiolabeled as 
a result of binding to each of the tested mRNAs. Fig.  1, a 
and b  also show the influence of increasing ionic strength 
(40-500 mM KCI) on the binding. A final concentration of 
100 mM KCI resulted in the most complex protein binding 
pattern (Fig.  1 a, lane 2), and was therefore chosen as the 
standard  condition.  When  the  effect of increasing  ionic 
strength on the stability of the formed RNP particles was 
tested, marked differences were found: only the 54- and 56- 
kD polypeptides (p54 and p56) remained bound at KCI con- 
centrations >100 raM, with p54 and p56 showing differential 
stabilities at higher ionic strengths (the ionic and other bind- 
ing characteristics of  these and other RNP complexes will be 
described in detail elsewhere; Murray, M., manuscript in 
preparation). The effect  of adding heparin and spermidine as 
nonspecific polyanion and polycation competitors was also 
tested. Upon addition of heparin (Fig. 1 b), 1954 and p56 as 
well as p60 were still bound, whereas binding of pl00 was 
reduced. Addition of spermidine had only minor effects. 
When the selectivlty of the binding assay was examined by 
competition with other RNAs, tRNA had no specific effect, 
except at higher concentrations (10 and 20 mg/ml) that selec- 
tively reduced p42 binding (results with non-polyadenylated 
mRNA are shown in Fig.  1 c).  Similarly, single-stranded 
DNA  or  total nonpolyadenylated RNA  specifically com- 
peted  p42  without affecting the  other  proteins'  binding. 
Competition with either 20 mg/ml poly(A) (Fig. 1 c, lane 6), 
1 mM 7-methyl-guanosine triphosphate cap analogue, or 1 mM 
5-brUTP  (not shown) had no significant effect.  However, 
when increasing amounts of total ovary RNA were used for 
competition (Fig. 1 d), p60 was the first protein whose bind- 
ing was competed, while the other polypeptides with the ex- 
ception of p42,  were competed by increasing amounts of 
ovary RNA. 
Competition with total ovary RNA was also studied with 
radiolabeled mRNA to which a nonradiolabeled poly(A) tail 
Figure  3.  Sedimentation analysis of ribonucleoprotein particles 
formed in vitro. RNPs formed in vitro from radiolabeled mRNA 
with nuclear or cytoplasmic proteins were sedimented through 
glycerol gradients. Total proteins of germinal vesicles (a) or cyto- 
plasmic LSS (b)  from 50  stage VI oocytes were incubated for 
20 h with substrate mRNA (an equal number of counts per minute 
of non- and polyadenylated), and centrifuged through  10-30% 
glycerol gradients. UV-cross-linking and the standard assay were 
performed on each fraction. Lanes 2-22 correspond to every sec- 
ond fraction of the gradient (from top to bottom). The positions of 
42S and 80S (vertical bars in a from left) were determined in a par- 
allel gradient. The dots in a indicate p60, and in b pl00, p70, p60, 
p56, and p54. 
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Polypeptide composition of the 6S frac- 
tion used for isolation of  p54 and p56, a, 
lane  1:  Coomassie  blue-stained  SDS- 
PAGE (10%). The specificity  of  the anti- 
bodies against  p54 and p56 was tested by 
immunoblotting  after separation  of  50 #g 
of ovary S100 supernatant  by SDS-PAGE 
00%) (a lane 2, Ponceau  S-stained  nitro- 
cellulose; lane 3, autoradiograph  of ~25I- 
Protein  A  bound  immunocomplexes), 
and after two-dimensionai  electrophore- 
sis of total soluble proteins from unfer- 
tilized eggs (isoelectric focusing (IEF), 
first dimension; and SDS-PAGE (SDS; 
10%),  second dimension; b,  Ponceau 
S-stained nitrocellulose; c,  autoradio- 
graph). The reference proteins BSA and 
actin are indicated in b by arrows (B, A). 
showed that 1360 corresponded to the 60-kD mRNP-POly- 
peptide described by Dearsly et al. (1985).  Our results not 
only showed that p60 had a high affinity for poly(A), but that 
it binds  nonpoly(A)  sites  (which  were  not competed for 
by poly(A)) and that polyadenylation also had a stabilizing 
effect on these other nonpoly(A) binding sites of p60. 
Despite the obvious selectivity of  binding of these proteins 
for mRNA it has not been possible to demonstrate specificity 
for any particular  mRNA.  A  variety of partial  lamin LI 
mRNAs, generated by the use of unique restriction sites in 
the LI eDNA (see Krohne et al., 1989), yielded similar pro- 
tein binding patterns. Alternatively, when other radiolabeled 
Xenopus mRNAs  transcribed  from  cDNAs  encoding  the 
histone-binding proteins N1 CKleinsehmidt et al., 1986) and 
nucleoplasm (Dingwall et al., 1987) or the nucleolar protein 
NO38 (Schmidt-Zaehman et al., 1987) were used, the same 
mRNA binding proteins  were  detected in the  complexes 
formed. Moreover, when RNA transcribed from the Blue- 
script vector alone was tested, it was also bound by the same 
set of proteins. Since the oocyte is known to stably store a 
vast pool of poly(A)-rich RNAs containing interspersed re- 
peat sequences (Anderson et al., 1982) which are nontrans- 
latable (Richter et al., 1984), the seeming lack of specificity 
observed  in our in vitro assay may reflect the biological 
group  function of these proteins.  Alternatively, it may of 
course also be that the assay lacks some component, e.g., 
one involved in nuclear RNP assembly, that may be neces- 
sary for specific mRNP assembly. At any rate, the described 
in vitro assay fulfills our intentions of a general biochemical 
screening test to detect soluble mRNA binding proteins. 
Compartmentalization of  RNA Binding Proteins 
in the Oocyte 
To determine the cellular distribution of the mRNA bind- 
ing proteins,  stage VI oocytes were dissected, nuclei and 
ooplasms were manually separated, and nuclear lysates and 
cytoplasmic supernatants were used for the RNA binding as- 
say. Exclusive binding of polyadenylated  mRNA by p60 was 
detected (Fig. 2, lanes I and 2), whereas p42, p54, p56, p90, 
p95, and pl00 bound to non-polyadenylated  mRNA (lanes 3 
and 4).  This selective binding of p60 to polyadenylated LI 
mRNA  at  nonpoly(A)  sites,  together  with the  enhanced 
stabilization effect  of  polyadenylation  on p60 binding outside 
of  the poly(A) tail (see above), indicates that p60 can interact 
with multiple binding sites in mRNAs, including regions up- 
stream of the poly(A) tail, that have conformations depen- 
dent on the polyadenylation state. Clearly, p60 is present in 
both the nucleus and cytoplasm, p90 and p95 are enriched 
in the nucleus, and p42, p54, p56,  and pl00 are primarily, 
if not exclusively localized in the cytoplasm (Fig. 2). The in- 
tracellular compartmentalization of p54  and p56  was  in- 
dependently confirmed by protein blotting with the antibod- 
ies described below. 
To characterize the RNPs formed in vitro, they were cen- 
trifuged through a glycerol gradient: a mixture of non- and 
polyadenylated  mRNA was incubated for 20 h with either the 
nuclear or cytoplasmic soluble proteins from 50 oocytes, fol- 
lowed by UV cross-linking of each gradient fraction and fur- 
ther processing. The result (Fig. 3 a) showed that p90 and 
p95 did not assemble into RNPs larger than 42S, whereas 
p60  was  recovered  in  a  range  of  different-sized  RNPs 
sedimenting across the gradient, including particles of more 
than 80S. The selective appearance of p60 in fast-sediment- 
ing RNPs may reflect multiple p60 association, either alone 
or in combination with other proteins  that are  indirectly 
bound and therefore not radiolabeled. 
In contrast to the RNPs assembled with nuclear proteins, 
those formed with cytoplasmic proteins (Fig. 3 b) sediment 
throughout the gradient, with each of the major RNA-bound 
proteins present in every size class, resembling the common 
distribution ofpolypeptides in native poly(A)+ mRNP parti- 
cles (Darnbourgh and Ford, 1981). The inclusion of proteins 
p54, p56, p60, p70, and pl00 in RNPs of  every size class may 
be taken to indicate that they form a general mRNP struc- 
ture. Whether the widely variable sizes of the RNPs formed 
in vivo are due to incomplete assembly or to associations of 
additional components remains to be examined. 
Purification of  p54 and p56 and Production 
of  Antibodies 
The major soluble cytoplasmic proteins with mRNA binding 
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Binding Proteins 
When S100 extract proteins were separated by sucrose and 
glycerol  gradient  centrifugations  and  assayed  for  mRNA 
binding (Fig. 5 a), p60, pT0, and p42 were detected in slow 
sedimenting (,x,4.5S) particles, indicative of monomers. In 
contrast, both p54 and p56 displayed the same monodisperse 
distribution with a peak at '~6S. A third, much larger parti- 
cle, which contained protein pl00, appeared in a somewhat 
broad distribution with a mean of ~15S.  Thus, three differ- 
ent particles can be defined on the basis of their mRNA bind- 
ing. However, when the fractionated S100 extract was exam- 
ined by immunoblotting (Fig. 5 b), p54 and p56 were present 
over an extended range of particles, from -6S to ~15S parti- 
cle fractions, albeit at different intensities.  The absence of 
mRNA binding by p54 and p56 in the *15S particles (com- 
pare  lanes  8  and  18 of Fig.  5,  a  and  b)  may be  due  to 
modifications or to interference by additional components in 
the  15S particles. 
Dependence of  mRNA Binding Ability on Kinase 
Acavity  and Protein Phosphorylation 
When aliquots of fractions containing the 4.5S, 6S, and 15S 
Figure 5.  Sedimentation  analysis of particles  containing  mRNA 
binding  proteins.  Ovary  S100 extract  was  fractionated  (5-30% 
glycerol gradient; 400-#1 fractions) and 5 #l of every second frac- 
tion assayed (a) for mRNA binding using polyadenylated mRNA 
or (b) by immunoblot with antibodies against p54 and p56, as in 
Fig. 4 (no protein was loaded from fraction  16). The dots to the 
left in a indicate pl00,  p70, p60, p56, and p54 (10% SDS-PAGE). 
The ~4.5S mRNA binding particle peak is centered at fraction 6, 
,x6S particle peak at fraction 8, and '~15S particle peak at fraction 
18. The position of reference proteins of known S value were deter- 
mined in a parallel gradient (from left to right, at top; 4.3S,  11.3S, 
and  16.5.S). 
potential, i.e., p54 and p56, were purified from ovary S100 
supernatant fractions in a three step scheme originally devel- 
oped for the purification of the  14.5S  ATPase homooligo- 
meric ring shaped particle (Peters et al.,  1990). After anion 
exchange chromatography,  fractions containing the  97-kD 
polypeptide of the 14.5S particle were concentrated by am- 
monium sulfate precipitation, and the '~6S particle contain- 
ing p54 and p56 was separated by velocity gradient centrifu- 
gation. During all stages of purification, p54 and p56 were 
observed in approximately equimolar amounts as estimated 
by SDS-PAGE and Coomassie blue staining.  Because p54 
and p56 appear as subunits of a discrete particle, antibodies 
were raised against both p5a and p56 (Fig. 4). The antibod- 
ies obtained were specific for p54 and p56 (Fig.  4  a, lane 
3; Fig. 5 b; Fig. 8, b and c), recognizing all their major iso- 
forms (Fig. 4  c  and Fig.  8, d  and e). 
Figure 6. Influence of protein phosphorylation on mRNA binding. 
The influence of protein phosphorylation  on mRNA binding was 
probed by assaying fractionated particles after phosphatase  treat- 
ment.  (a) 4.5S and 6S (lanes 1 and 2) and  15S particles  (lanes 3 
and 4) of fractionated ovary $100 extract were treated with alkaline 
phosphatase and tested for mRNA binding with polyadenylated Ll 
mRNA. 7.5 #1 of  fractions 6 or 16 (see Fig. 5) were incubated with- 
out (lanes 1 and 3) or with (lanes 2 and 4) alkaline phosphatase 
(20 U) in the absence of ATP for 30 min at 37°C, and then brought 
to the standard mRNA-binding conditions (on ice); polyadenylated 
radiolabeled  mRNA was added and the standard  assay was con- 
tinued. In both a and b, the dots indicate pl00,  p70, and p60; and 
the arrowheads, p56 and p54 (10% SDS-PAGE). (b) 15S particles 
were treated with varying amounts of alkaline phosphatase at 20°C 
and then tested for mRNA binding. 4.5/~1  of fraction 18 was treated 
with 0, 2, or 10 U of alkaline phosphatase (lanes 1-3) in the pres- 
ence of I mM ATP at 20°C for 30 min, and then tested for mRNA 
binding as in a. 
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binding. (a)  15S  particles (4.5 #1  of fraction  18; 
shown in Fig. 5) were incubated with 2 #Ci 3,32p  - 
ATP in the presence of 10 mM MgC12 for 30 min at 
20°C, and immunoprecipitated with p54/p56 (lane 1 
and 3),  or control antibodies (lane 2 and 4).  Au- 
toradiographic exposure (lanes 1 and 2) and Coomas- 
sic blue staining (lane 3 and 4) detect the polypeptides 
co-immunoprecipitated  with p54 and p56. Aliquots of 
15S  particle  kinase  reaction  were  incubated with 
p54/p56 antibodies covalenfly  bound to Sepharose or 
control serum adsorded to protein A Sepharose in 
buffer B. In lane 1, the dots indicate phosphorylated 
polypeptides of "o120 and "ol00 kD, and arrowheads 
indicate p54 and p56; in lane 3, the dots indicate poly- 
peptides of ,,o160, "o120, ,o70, and "o60 kD. The in- 
tensely stained polypeptides in lanes 3 and 4 are im- 
munoglobin  heavy and light chains. (b) Protein kinase 
activity sedirnenting  with the 15S mRNA binding par- 
ticles (lane 1 ) was inhibited by the addition of  heparin 
to 0.1 mg/ml (lane 2). 5 #1 of fraction 18 (shown in Fig. 5) was incubated with 2 #Ci32p-ATP in the presence of 10 mM MgCI2 for 30 min 
at 20°C and the TCA-preeipitable  proteins separated by SDS-PAGE (10%). (c) The influence of protein kinase activity on mRNA binding 
of 6S and 15S particles was tested after incubation under conditions which were either permissive (lanes 2 and 3) or inhibitory for protein 
kinase activity (lanes 4 and 5). Aliquots (7.5 #1) of fraction 13 containing both 6S and 15S particles (see Fig. 5) were tested for mRNA 
binding under standard assay conditions (lane 1), or after incubation at 20°C for 30 min under suboptimal (lane 2;  1 mM ATE 2 mM 
MgCI2) or optimal protein kinase conditions (lanes 3-5; 10 mM ATE 10 mM MgC12). Heparin (0.1 mg/ml) was present throughout the 
30-min incubation at 20°C (lane 4), or added immediately before the mRNA binding incubation period (lane 5). The arrowheads indicate 
p56 and p54; the dots, pl00, p70, and p60 (10% SDS-PAGE). Autoradiographs are shown in b and c. 
particles (Fig.  5) were treated with phosphatase and then 
tested for mRNA binding, the binding of p60, pT0, and pl00 
was no longer observed (Fig. 6 a, lanes 2 and 4).  Surpris- 
ingly, the loss of 13100 mRNA binding in the 15S particles 
was accompanied by the appearance of mRNA binding by 
p54 and p56.  This was further investigated by limited phos- 
phatase treatment of the  15S particles (Fig.  6 b).  Loss of 
mRNA binding by pl00 was accompanied the appearance of 
mRNA binding of  p60 (lane 2), which was greatly enhanced 
upon total loss of pl00 binding activity (lane 3).  Since the 
native particle only exhibits mRNA binding by pl00 (Fig. 5), 
this indicates that the organization of the 15S particles is de- 
pendent on phosphorylation, and that the mRNA binding of 
p54, p56, and p60 is regulated by their association within the 
15S particles. 
The 15S particle was tested for protein kinase activity and 
the endogenous substrates analyzed after SDS-PAGE separa- 
tion of particles immunoprecipitated with the p54/p56 anti- 
bodies (Fig. 7 a). Both p54 and p56 were detected as sub- 
strates of the endogenous kinase (Fig.  7  a,  lane 1).  The 
results also showed co-immunoprecipitation of phosphory- 
lated polypeptides of "ol00 and ,o120 kD (lane/), and poly- 
peptides of "o60,  "o70, "o120, and "o160 kD by Coomassie 
blue staining (lane 3). The phosphorylated "ol20-kD poly- 
peptide migrated slightly slower than the Coomassie blue- 
stained ,M20-kD polypeptide. While the exact composition 
of the p54/p56  15S particles is under further investigation, 
these results establish both their heterotypic complex nature 
and that they are substrates of an endogenous kinase. 
As several protein kinases are sensitive to inhibition by 
heparin  (e.g.,  Hathaway and Traugh,  1982;  Erikson and 
Mailer,  1986),  the  15S  gradient  fractions  were  assayed 
directly for protein kinase activity (Fig. 7 b) and the effects 
of heparin examined. Heparin was found to inhibit the pro- 
tein kinase acting on p54 and p56 (Pig. 7 b, lane 2). When 
the 15S gradient fractions were assayed directly for protein 
kinase activity (Fig. 7 b), the 120-kD was detected as the pri- 
mary  substrate,  perhaps  corresponding  to  the  protein 
reported by Mulner-Lorillon et al. (1988) to show increased 
phosphorylation upon  microinjection of purified Xenopus 
ovary kinase II into fully grown oocytes. The more intense 
radiolabeling of the  120-kD  component after the 30-min 
reaction, as compared with that observed after immunopre- 
cipitation (after a 14-h incubation in the presence of 0.5 mM 
ATP) probably reflects a greater sensitivity of the 120-kD 
polypeptide to endogenous phosphatases. 
We then further used the inhibition of kinase activity to 
probe  whether the enzyme activity itself is necessary for 
mRNA binding. Fig. 7 c shows the effect of heparin inhibi- 
tion of  protein kinase activity on mRNA binding of a mixture 
of particles (fraction 13,  see Fig.  5):  Addition of heparin 
alone (Fig. 7 c, lane 4) abolished mRNA binding of pl00 but 
did not considerably affect the mRNA binding activity of the 
other proteins. The 15S particles, however, containing pl00 
as well as p54, p56,  and p60 were entirely excluded from 
mRNA binding.  In contrast,  the mRNA binding proteins 
present in the smaller particles  (p70, p60,  p56,  and p54) 
bound mRNA independent of heparin addition (Fig.  7  c, 
lanes 4 and 5). The effect of heparin on mRNA binding of 
pl00 was observed even when the heparin was added after 
the kinase incubation period (Fig. 7 c, lane 5). Inhibition of 
pl00 mRNA binding by heparin alone suggested that stable 
phosphorylation was not sufficient to allow the binding of 
this protein, and hence of the 15S particles, but that protein 
kinase activity was required. Binding of both subunits of the 
6S particle, i.e., p54 and p56, was found to increase after in- 
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prepared from ovaries, unfertilized eggs or staged embryos, in comparison with somatic tissue, were tested with polyadenylated  mRNA. 
50/~g of S100 extract from liver (lane 1), immature ovary (lane 2), mature ovary (lane 3), unfertilized eggs (lane 4), and embryos of 
stage 6, 9, 11.5, 15, 22, 28 (lanes 5-10) were incubated with radiolabeled mRNA having a nonradiolabeled  poly(A) tail, under standard 
conditions (except for liver, where 20 mM vanedylate was also included), and the proteins separated on a 12% gel. The dots to the left 
indicate p56, p54, and a 48-kD polypeptide, and those to the fight indicate pl00, pT0, and p60. The intensity of the 48-kD polypeptide 
in lane 2 suggests that it has maximal RNA binding early in oogenesis. (b and c) Immunoblot with p54/p56 antibodies, corresponding 
(lanes 2-10) to 50 #g of the same S100 extracts tested for mRNA binding in a. The proteins were separated on a 10% gel, and the blot 
probed with a 1:20,000 antibody dilution using ~:5I-Protein  A for detection. A longer exposure of lanes 6--10  is shown in c. (d and e) Im- 
munodetection of p54 and p56 isoforms in previtellogenic oocyte (d) and unfertilized egg (e). The low-speed supernatant equivalent of 
a single stage II ooeyte and unfertilized egg were separated by NEPHGE in the first dimension with BSA (open circles) and actin (filled 
circles) added as references, and 10% SDS-PAGE in the second dimension. The proteins were transferred to nitrocellulose and processed 
as in b. 
cubation under conditions of kinase type H phosphorylation 
(Fig. 7 c, lane 3). Again, addition of heparin prevented this 
increase (Fig. 7 c, lanes 4 and 5). 
The heparin inhibition of mRNA binding by pl00 in the 
15S particles did not facilitate mRNA binding of any of the 
other proteins, in contrast to the phosphatase effect of ren- 
dering p60, or p54 and p56, in the 15S particles, competent 
for mRNA binding (Fig. 6). Together, these results indicate 
that in the 15S particles, the mRNA binding proteins are or- 
ganized in a manner which is, at least partly, dependent on 
phosphorylation, and that initial mRNA binding by these 
particles via pl00 requires an active protein kinase. 
Developmental Regulation of Protein mRNA 
Binding Ability 
S100 extracts were prepared from various stages of oogene- 
sis  and  embryogenesis to  determine whether the mRNA 
binding of  the soluble proteins is developmentally regulated. 
Fig. 8 a  shows a panel of mRNA binding assays with poly- 
adenylated substrate  mRNA and  S100  extract from such 
stages, in comparison with S100 extract from Xenopus liver 
in which significant amounts of RNA binding-proteins were 
not detected (lane/). The binding by p54 and p56 increased 
during oogenesis, declined between embryonic stages 6, 9, 
and 11.5 and was lost between stages  11.5 and 15. 
After the observation of reduced mRNA binding by p54 
and p56 in postgastrula stages, we examined the presence of 
these two polypeptides in the SI00 extracts by immunoblot- 
ting with antibodies to p54 and p56 (Fig. 8, b and c): both 
polypeptides were found at their highest level early in oogen- 
esis and then to gradually decrease during oogenesis and 
early embryogenesis. The substantial reduction of p54 and 
p56 in the soluble pool of stage 15 and later embryos clarifies 
the loss of mRNA binding noted in these stages. Upon very 
long exposure time, some p54 and p56 are detected in these 
postgastrular extracts (not shown). The decline of p54 and 
p56 levels during oogenesis, which includes maturation to 
the egg, is accompanied by an increase in their observed 
mRNA binding (Fig. 8, a and b), indicating that the mRNA 
binding of these proteins is not solely determined by their 
protein levels. Some insight to this observation was obtained 
by two-dimensional analysis of p54 and p56 of previtello- 
genic oocytes (Fig. 8 d) and unfertilized eggs (Figs. 8 e and 
4 c), showing a variety of isoforms, and a significant modifi- 
cation of p54 to more acidic isoforms in the unfertilized egg. 
The acidic isoforms of p54 and p56 in the unfertilized egg, 
are most probably due to phosphorylation upon maturation 
of the oocyte, and correlate with an increased mRNA bind- 
ing. Two dimensional immunoblots of the immature and ma- 
ture ovary $100  extracts  were indistinguishable from the 
previtellogenic oocyte immunoblot (Fig. 8 d), indicating that 
additional factors must regulate the mRNA binding which 
increases between these oogenic stages. 
Discussion 
Nucleocytoplasmic transport of mRNA is accompanied by 
a change in its associated proteins, from hnRNP to mRNP 
(e.g.,  Lindberg  and  Sunquist,  1974;  Beyer et  al.,  1977; 
Greenberg,  1981; Mayrand and Pederson,  1981), with the 
cytoplasmic  mRNA-associated  proteins  probably  serving 
roles in stabilization, translation, and intracellular localiza- 
tion of mRNAs (for review see Dreyfuss, 1986).  To gain in- 
sight into the regulatory principles involved in the formation 
and stabilization of mRNPs we systematically searched for 
soluble mRNA binding-proteins, using the amphibian oocyte 
as a particularly suitable cell because of its high production 
rate and storage capacity of maternal mRNPs. 
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soluble mRNA-binding  proteins,  we have detected in the 
cytoplasm of  Xenopus oocytes, eggs, and embryos, three dis- 
crete and compositionaUy  different forms of particles con- 
taining proteins that readily and stably associate with defined 
mRNA molecules resulting  in  the  formation  of mRNPs. 
Obviously these free, i.e., unoccupied proteins and particles 
are excellent candidates  for a role in the translational  regula- 
tion of the stored maternal  mRNAs characteristic  of these 
stages. Our demonstration of a cytoplasmic pool of mRNA- 
binding proteins also raises the general question of the regu- 
lation of their activity in relation  to mRNP and polyribo- 
some formation. 
Several  observations  suggest  that  the  mRNP  particles 
formed in vitro are specific  and biologically relevant:  (a) 
they are selective for mRNA and can be competed by compe- 
tent, i.e., ovarian RNA. (b) The mRNPs formed are similar 
in size to native mRNPs from the same cell and also seem 
to have several polypeptides in common, including p54 and 
p56  (as  shown  by immunoblotting;  data  not  shown),  al- 
though a direct correlation is not possible (c.f. Darnbourgh 
and Ford,  1981; Richter and Smith,  1983; Dearsly et al., 
1985;  Cummings  and  Sommerville,  1988;  Swiderski and 
Richter,  1988). (c) The complexes formed exclude other nu- 
cleic acid-binding  molecules such as ribosomal proteins, 
specific hnRNA-binding proteins (Dreyfuss,  1986), the small 
polypeptides binding to AUUUA motifs (see Malter,  1989), 
and histones which are known to be abundant in oocyte $100 
extracts  and to avidly bind to RNA in vitro (see Laskey et 
al.,  1978;  Kleinschmidt  et al.,  1985).  (d)  The observed 
changes in two of the polypeptides (p54 and p56) correlate 
with the developmentally regulated translational  activation 
of stored maternal  mRNAs. 
Three Forms of Soluble mRNA Binding Particles 
The smallest class of"free" proteins observed are the ,~4.5S 
particles containing  1342, p60, and p70, probably in the form 
of individual molecules. Of these, p60 occurs in both the nu- 
cleus and the cytoplasm, suggesting that it is an early assem- 
bly protein in mRNP formation.  It is probably identical  to 
the poly(A)-binding protein identified  in amphibian  oocyte 
hnRNPs with which it immunologically cross-reacts (this 
study; see Kloetzel et al., 1982; Dearsly et al.,  1985; Kick 
et al.,  1987; Cummmings and Sommerville,  1988).  How- 
ever, our present findings also show that p60 can bind, in ad- 
dition to the poly(A) tail, to upstream sites of mRNA and 
to nonpolyadenylated  mRNA as well. The polypeptide p70, 
which is very basic and found among the soluble cytoplasmic 
proteins,  may be related  to the  ,x,70-kD poly(A)-binding 
mRNP component (Blobel, 1973; Sachs et al., 1986; Ullrich 
et al.,  1988) identified  in Xenopus oocytes and embryos by 
Swiderski  and Richter (1988) and Zelus et al.  (1989),  al- 
though the latter  authors  were unable to detect it in any 
preneurula stage by immunoblots. 
The population of"o6S particles includes complexes of the 
avidity mRNA-binding  polypeptides p54 and p56,  in near- 
equimolar stoichiometry,  suggestive of a heterodimer,  and 
these polypeptides have also been identified as constituents 
of oocyte mRNP particles of a  wide range  of sizes.  This 
correlates with results described in previous reports. A poly- 
peptide of •56  kD has been reported in Xenopus oocytes as 
a constituent of 40-60S RNP particles by Richter and Smith 
(1983, 1984), and two polypeptides of,x,54 and ,x,56 kD have 
been shown to occur in 40-120S RNPs by Sommerville and 
colleagues (Kloetzel et al., 1982; Dearsly et al., 1985; Cum- 
mings and Sommerville,  1988). Neither of these groups has 
identified these two polypeptides among the soluble proteins 
of mature  oocytes, and  the 6-18S  particles  described by 
Cummings  and Sommerville (1988) which do contain a 56- 
kD polypeptide, were only found in previtellogenic  oocytes. 
The results of our piesent study show that the complex of 
p54 and p56,  i.e., the 6S particle,  is cytoplasmic and that 
both subunits  bind mRNA independent  of its polyadeayla- 
tion, in a very stable way, as demonstrated by the resistance 
to elevated ionic strength.  The same fraction of 6S particles 
also contains protein kinase activity,  but we have not yet 
resolved whether p54, p56, or both carry the enzyme activ- 
ity, or whether there is an additional minor protein responsi- 
ble for the phosphorylation of p54 and p56, which has as yet 
escaped our detection. 
Using the p54/p56 antibodies described here, we have iso- 
lated cDNAs from )~gtll expression libraries containing  the 
major portion of the coding sequence (>40 kD) of p56. The 
partial amino acid sequence determined therefrom reveals a 
remarkable richness  in glutamine  (Q)  residues,  including 
five QQ dipeptides, in bydroxyamino acids, (S,T), proline (P), 
and arginine  (R) residues,  with a  conspicuous QQRPPP- 
RRFQQRF motif. We did not detect any of the known RNA- 
binding  consensus motifs (Sachs  et al.,  1986;  for review 
see Bandziulis  et al.,  1989).  Extensive  searches  of several 
protein and nucleic acid sequence data banks (e.g., Swiss 
Prot Release 14.0, Protein Identification  Resource Release 
25,  EMBL release 24, and Genbank release 64) have not 
shown significant  homology of this sequence to any of the 
known RNA-binding proteins.  Therefore,  we conclude that 
p56,  and probably also p54, represent new kinds  of RNA 
binding  proteins. 
The larger mRNA binding particles,  with a broad distribu- 
tion centered at ,x,15S, are the only moieties containing pl00 
and exhibit exclusive mRNA binding by pl00 in the native 
particles.  Cummings and Sommerville (1988) described, in 
previteUogenic  oocytes, a  fraction  of 6-18S particles with 
phosphopolypeptides at 16, 28, and 56 kD, which also con- 
tained  kinase  activity,  but these authors  did  not test for 
mRNA binding.  Our immunoprecipitation  of an ,x,100-kD 
phosphopolypeptide with p54/p56 antibodies,  together with 
the increased mRNA binding  activity of p54, p56, and p60 
after phosphatase treatment of 15S particles,  indicates  that 
this set of mRNA binding polypeptides is present in the same 
particles.  It also suggests that the mRNA binding  of p54, 
p56,  and p60 is regulated  by their  association  in the  15S 
particles. 
Dependence of mRNA Binding on Phosphorylation in 
All Three Particle Classes 
All five major mRNA-binding proteins present in the cytosol 
fraction of oocytes and eggs occur in phosphorylated forms. 
Intense phosphorylation has also been reported for polypep- 
tides of 56 and 60 kD present in particle fractions from pre- 
vitellogenic  oocytes (Cummings  and Sommerville,  1988), 
which may be identical to the proteins discussed here. More- 
over, we have found that the mRNA binding ability of these 
five polypeptides depends on their phosphorylation, as it is 
lost upon phosphatase treatment  (960, p70, and pl00) or in- 
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nase activity (p54 and p56).  The apparent  insensitivity  of 
both polypeptides of the 6S particle to phosphatase treatment 
is probably explained  by efficient rephosphorylation  by ki- 
nase activity intrinsic to these particles.  The modification of 
p54 and p56 to more acidic isoforms in the unfertilized  egg 
is associated with an observed increase in their mRNA bind- 
ing (Fig.  8). 
The observed developmental  pattern of mRNA binding of 
p54 and p56 would be compatible with a regulatory role of 
the 6S particle in polyribosome formation.  This may relate 
to the findings of dependence of translational  inactivation on 
the phosphorylation state of mRNA-associated proteins,  as 
observed when native oocyte  mRNPs were translated in vitro 
after  phosphatase  treatment  (Kick  et  al.,  1987).  These 
results  suggest  that  the  full  set of mRNA binding  phos- 
phoproteins  is necessary for mRNP stability and transla- 
tional  inactivation. 
Developmental Regulation of mRNP Formation 
The pattern of mRNA binding of p54 and p56 during oogen- 
esis and embryogenesis seems to be correlated with mRNP 
formation  during development:  increased rnRNA binding is 
concomitant with the increase in mRNP formation  during 
oogenesis,  including  oocyte maturation  and egg formation 
(Ballantine  et al.,  1979; Kandror  et al.,  1989), and loss of 
p54 and p56 from the soluble pool later in embryogenesis 
coincides with the increased translation  of stored mRNAs 
(Ballentine  et al.,  1979; Woodland et al.,  1979; Lee et al., 
1984; Stick and Hausen, 1985).  Since some low-level pre- 
mRNA transcription  has been observed in stages earlier than 
midblastula  (Shiokawa  et al.,  1989),  the soluble pools of 
mRNA-binding proteins would also allow for the continuous 
assembly of new  transcripts  into  mRNPs.  The  observed 
mRNA binding of i360, p70, and pl0O throughout  early em- 
bryogenesis (to stage 28) suggests that they may continue to 
serve as complex partners  of newly synthesized  mRNAs. 
This is not unexpected as it has been shown in other cells 
(Greenberg  and  Carroll,  1985) that  the  major  mRNA- 
binding proteins of mRNPs are also found on polyribosome- 
associated mRNA. 
We postulate that the mRNA binding  proteins identified 
here, specifically the 6S particles p54 and p56, are generally 
involved in maternal mRNP formation in a mode largely in- 
dependent of the developmentally regulated  deadenylation 
and polyadenylation  of mRNAs which occurs in the same 
system (e.g., Ruiz i Altaba et al.,  1987; Hyman and Wor- 
mington,  1988; McGrew et al.,  1989; Duval et al.,  1990; 
Paris and Philippe,  1990). As the mRNA binding activity of 
these proteins  depends on their  phosphorylation,  the ob- 
served increase in kinase II activity upon oocyte maturation 
(Kandror et al., 1989) and the postgastrular increases in cer- 
tain phosphatase activities  (Miyahara et al., 1982) may play 
key roles in regulating complex formation,  and thus transla- 
tional  activity,  of mRNPs. 
General Conclusions 
Although the amphibian  oocyte builds up large stores of in- 
activated mRNA and therefore contains relatively high con- 
centrations  of the free, i.e., soluble forms of mRNA-binding 
proteins described here,  the basic requirement of specific 
complex formation  of certain proteins with certain mRNAs 
also has  to be met in other kinds  of cells,  although  on a 
smaller scale. Indeed, a poly(A) binding protein of ~70 kD 
has been identified in a wide variety of cell types and species 
(Sachs et al., 1986; Ullrich et al., 1988; Zelus et al., 1989; 
for review see Jackson and Standart,  1990). Thus, pools of 
soluble mRNA-binding proteins may be a rather general and 
functionally  fundamental  "housekeeping"  feature of diverse 
cells whereas the build up of a large store of these proteins 
may be special  for oocytes, and this  mechanism  may be 
necessary for early embryogenesis (see also Drawbridge et 
al.,  1990). 
We are also aware of the problems that proteins  destined 
for binding a specific kind of nucleic acid,  i.e., in this case 
certain  mRNAs,  face  in  their  cytoplasmic  environment 
dominated by an  abundance  of negatively  charged  mole- 
cules,  including  most proteins and nucleic acids other than 
mRNAs.  Therefore,  we  also  postulate  that  the  mRNA- 
binding proteins and particles described here are themselves 
controlled by a category of special proteins,  similar  to the 
anionic  proteins regulating  storage of histones and  hence 
chromatin  formation  (e.g.,  Laseky  et  al.,  1978;  Klein- 
schmidt et al., 1985; Smith and Stillman,  1989). The avail- 
ability of antibodies to these proteins,  and of cDNA probes, 
will allow us to identify  such molecules and elucidate the 
protein-RNA and protein-protein interactions  involved. 
We  thank  C.  DeVak,  B.  Fouquet,  H.  Herrmann,  T.  Hoeger,  and J. 
Kleinschmidt (German Cancer Research Center) for helpful discussions 
and encouragement, and John Sommerville (St. Andrews, Scotland) for the 
pt0 antisera.  We are especially grateful to Jan Peters (this center) for 
generously contributing fractionated protein. 
M. T. Murray was a fellow of the Alexander yon Humboldt Stiftung, 
and the project was supported by the Deutsche Forschungsgemeinschafi 
(SFB 229) to G. Krohne. 
Received for publication 4 May 1990  and in revised form 13 September 
1990. 
References 
Anderson, D. M., J. D. Richter, M. E. Chambeflin, D. H. Price, R. J. Britten, 
L.  D.  Smith,  and E.  H.  Davidson.  1982. Sequence  organization  of the 
poly(A) RNA synthesized and accumulated in lampbrosh chromosome stage 
Xenopus laevis  oocytes. J. Mol.  Biol.  155:281-309. 
Baliantine, J. E. M., H. R. Woodland, and E. A. Sturgess.  1979. Changes in 
protein synthesis during development of Xenopus laevis.  J. Embryol.  Exp. 
Morphol.  51:137-153. 
Bandziulis, R. J., M. S. Swanson, and G. Dreyfuss. 1989. RNA-binding pro- 
teins as developmental  regulators.  Genes & Dev.  3:431-437. 
Benavente, R., and G. Krohne. 1986. Involvement of nuclear lamins in postmi- 
totic reorganization of  chromatin as demonslrated  by microinjection of  lamin 
antibodies.  J.  Cell Biol.  103:1847-1854. 
Benavente, R., G. Krolme, and W.W. Franke. 1985. Cell type-specific expres- 
sion of nuclear lamina proteins during development of Xenopus laevis.  Cell. 
41:177-190. 
Beyer, A. L., M. E. Christensen, B. Walker, and W. M. Le Stourgeon.  1977. 
Identification  and characterization  of the packaging  proteins of core 40S 
hnRNP particles.  Cell.  11:127-138. 
Blobel, G. 1973. A protein of  molecular weight 78,000 bound to the polyadeny- 
late region of eukaryotic  messenger RNAs. Proc. Natl. Acad.  Sci.  USA. 
70:924-928. 
Brawerman,  G.  1989. mRNA decay: finding the right targets.  Cell.  57:9-10. 
Crawfurd, D. R., andJ. D. Richter. 1987. An RNA-binding  protein from Xeno- 
pus laevis is associated  with specific  message sequences.  Development. 
101:741-749. 
Cummings, A., and J. Sommerville.  1988. Protein kinase activity associated 
with stored messenger ribonucleoprotein  particles  of Xenopus oecytes. J. 
Cell Biol.  107:45-56. 
Darnbourgh, C.H., and P. J. Ford. 1981. Identification in Xenopus laevis of 
a class of oocyte-specific proteins bound to messenger RNA. Eur. 2.  Bio- 
chem.  113:415-424. 
The Journal  of Cell Biology, Volume 112,  1991  10 Davidson, E. H. 1989. Gene Activity in Early Development. Academic Press, 
Orlando, FL. 
Dearsly,  A.  L.,  R.  M.  Johnson,  P.  Barrett,  and  J.  Sommervifie.  1985. 
Identification  of a 60-kDa phosphoprotein that binds stored messenger  RNA 
of Xenopus oocytes. Fur. J. Biochem.  150:95-103. 
Diguam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983.  Accurate transcrip- 
tion initiation by RNA polymerase II in a soluble extract from isolated mam- 
malian nuclei. Nucleic Acids Res.  11:1475-1489. 
Dingwall,  C., S.M. Dllworth,  S. J. Black, S. E. Kearsey, L. S. Cox, and R. A. 
Laskey.  1987.  Nucleoplasmin eDNA sequence reveals polyglutaimc acid 
tracts and a cluster of sequences homologous  to putative nuclear localization 
signals. EMBO (Fur. Mol. Biol.  Organ.) J. 6:69-74. 
Dolecki, G. J., and L. D. Smith. 1979. Poly(A)  + RNA metabolism during oo- 
genesis in Xenopas laevis. Dee. Biol.  69:217-236. 
Drawbridge, J., J. L. Grainger, and M. M. Winkler. 1990. Identification  and 
characterization of the poly(A)-binding proteins from sea urchin: a quantita- 
tive analysis. Mol.  Cell.  Biol.  10:3994-4006. 
Dreyfuss, G. 1986.  Structure and function of nuclear and cytoplasmic ribonu- 
cleoprotein particles. Annu. Rev.  Cell Biol.  2:459-498. 
Dumont, J. N. 1972. Oogenesis inXenopus laevis (Dandin) I. Stages of oocyte 
development in laboratory malntafued  animals.  J. Morphol.  136:153-180. 
Dural, C., P. Bouvet, F. Omilli, C. Roghi, C. Dorel, R. LeGuellec, J. Paris, 
and H. B. Osborne. 1990. Stability of maternal mRNA in Xenopus embryos: 
role of transcription and translation. Mol.  Cell.  Biol.  10:4123-4129. 
Erikson, E., and J. L. Mailer. 1986. Purification and characterization of a pro- 
tein kinase from Xenopus eggs highly specific for ribosomal protein $6. J. 
Biol.  Chem.  261:350-355. 
Greenberg, J. R. 1980. Ultraviolet light-induced crosslinking  of mRNA to pro- 
teins. Nucleic Acids Res.  8:5685-5701. 
Greenberg, J. R.  1981.  The polysomal mRNA-protein complex is a dynamic 
structure. Proc. Natl. Acad.  Sci.  USA.  78:2923-2926. 
G-reenberg, J. R., and E. Carroll.  1985. Reconstitution of functional mRNA- 
protein complexes in a rabbit reticulocyte cell-free translation system. Mol. 
Cell Biol.  5:342-351. 
Hathaway, G. M., and J. A. Trangh. 1982. Casein kinases: multipotential pro- 
tein kinases. Curt.  Top.  Cell.  Reg.  21:101-125. 
Harem, J., M. Kazmaier, and I. W. Mattaj.  1987.  In vitro assembly of U1 
snRNPs. EMBO (Eur. Mol.  Biol.  Organ.) J.  6:3479-3485. 
Hunt, T.  1988.  Controlling mRNA lifespan. Nature (Lond.).  334:567-568. 
Hyman, L. E., and W. M. Wormington. 1988.  Translational inactivation of 
ribosomal protein mRNAs during Xenopus oocyte maturation. Genes & Dee. 
2:598-605. 
Jackson, R. J., and N. Standact.  1990.  Do the poly(A) tail and 3' untranslated 
region control mRNA translation? Cell.  62:15-24. 
Kandror, K. V., and A.S. Stepanov. 1988. Informosomes  and translational ac- 
tivity ofmRNA in eukacyotic cells (review). Mol. Biol.  (Mosc.).  22:23-34. 
Kandror, K. V., A. O. Benumov, and A.S. Stepanov. 1989.  Casein kinase II 
from Rana ternporaria  oocytes. Fur. J. Biochem.  180:441-448. 
Kick, D., P. Barrett, A. Cummings, and J. Sommerville. 1987.  Pbosphoryla- 
tion of a 60 kDa polypeptide from Xenopus oocytes blocks messenger RNA 
translation. Nucleic Acids Res.  15:4099-4109. 
Kleinschmidt, J. A., E. Fortkamp, G. Krohne, H. Zentgraf, andW. W. Franke. 
1985.  Co-existence of two different types of soluble hlstone complexes in 
nuclei of Xenopus laevis oocytes. J. Biol.  Chem.  260:1166-1176. 
Kleinschmidt, J. A., C. Dingwall, G. Maier, and W. W. Franke. 1986. Molec- 
ular characterization  of  a  karyophilic,  histone-binding  protein:  cDNA cion- 
ing,  amino acid  sequence  and  expression  of  nuclear  protein  NI/N2 of  Xeno- 
pus laevis.  EMBO (Eur. Mot.  Biol.  Organ.) J.  5:3547-3552. 
Kloetzel, P.M., R. M. Johnson, and J. Sommerville. 1982. Interaction of the 
hnRNA of amphibian oocytes with fibril-forming proteins. Fur. J. Biochem. 
127:301-308. 
Kozak, M.  1988.  A profusion of controls. J.  Cell Biol.  107:1-7. 
Krohne, G., S. L. Wolin, F. D. McKeon, and W. W. Franke. 1987.  Nuclear 
lamin LI ofXenopus laevis: eDNA cloning, amino acid sequence and binding 
specificity  of a member of the lamin B subfamily. EMBO (Eur. Mot.  Biol. 
Organ.) J.  6:3801-3808. 
Krohne, G., I. Waizenegger, and T. H. Htger. 1989. The conserved carboxy- 
terminal cysteine of nuclear lamins is essential for lamin association with the 
nuclear envelope. J.  Cell Biol.  198:2003-2011. 
Laskey, R. A., B. M. Honda, A. D. Mills, andJ. T. Finch. 1978. Nucleosomes 
are assembled by an acidic protein which binds histones and transfers them 
to DNA. Nature (Land.).  275:416-420. 
Lee, G., R. Hynes, and M. Kirschner. 1984. Temporal and spatial regulation 
of fibronectin in early Xenopus development. Cell.  36:729-740. 
Leibold, E. A., and H. N. Munro. 1988.  Cytoplasmic protein binds in vitro 
to a highly conserved sequence in the 5' untranslated region of ferritin heavy- 
and light-subunit mRNAs. Proc. Natl.  Acad.  Sci.  USA.  85:2171-2175. 
Lindberg, U., and B. Sunquist. 1974.  Isolation of messenger ribonucleopro- 
teins from mammalian cells. J. Mol.  Biol.  86:451-468. 
Matter, J.S. 1989. Identifcation of an AUUUA-specific  messenger  RNA bind- 
ing protein. Science (Wash.  DC). 246:664-666. 
Mayrand, S., and T. Pederson. 1981. Nuclear ribonuclear particles probed in 
living cells. Proc. Natl. Acad.  Sci.  USA.  78:2208-2212. 
McGrew, L.L., E. Dworkin-Rastl, M. B. Dworkin, and J.D. Richter. 1989. 
Poly(A) elongation during Xenopus oocyte maturation is required for transla- 
tional recruitment and is mediated by a short sequence element. Genes & 
Dee. 3:803-815. 
Melton, D. A., P.A. Krieg, M. R. Rehagliati, T. Maniatis, K. Zinn, andM. R. 
Green. 1984. Efficient in vitro synthesis  of biologically active RNA and RNA 
hybridization probes from plasmids containing a  bacteriophage SP6 pro- 
moter. Nucleic Acids. Res.  12:7035-7056. 
Miyahara, K., K. Shiokawa, and K. Yarnana. 1982.  Cellular commitment for 
post-gastrular increase in alkaline phosphatase activity in Xenopus laevis de- 
velopment. Differentiation.  21:45-49. 
Mulner-Lorillon, O., J.  Marot,  X.  Cayla, R.  Pouhle, and R.  Belle.  1988. 
Purification  and characterization of a  casein kinase II type enzyme from 
Xenopus laevis ovary. Fur. J. Biochem.  17l:107-117. 
Nieuwkoop,  P.  D.,  and J.  Faber.  1967.  Normal Table of Xenopus laevis 
(Daudin).  Elsevier/North Holland, Amsterdam. 
O'Farrell, P. H. 1975. High resolution two-dimensional electrophoresis of pro- 
teins. J. Biol.  Chem.  250:4007-4021. 
O'Farrell, P. Z., H. M. Goodman, and P. H. OTarrell. 1977. High resolution 
two-dimensional gel electrophoresis of basic as well as acidic proteins. Cell. 
12:1133-1142. 
Paris, J., and M. Philippe.  1990.  Poly(A) metabolism and polysomal recruit- 
ment of maternal mRNAs during early Xenopus development. Dev.  Biol. 
140:221-224. 
Peters, J. M., M. J. Walsh, and W. W. Franke. 1990. An abundant and ubiqui- 
tous homo-oligomeric ring-shaped ATPase particle related to the putative 
vesicle fusion proteins Sec18p and NSF. EMBO (Fur. Idol.  Biol.  Organ.) 
J.  9:1757-1767. 
Richter, J. D. 1987. Molecular mechanisms  of translational control during early 
development of Xenopus laevis.  In Translational Regulation of Gene Expres- 
sion. J. Ilan, editor. Plenum Publishing Corp., New York.  111-139. 
Richter, J. D., and L. D. Smith. 1983. Developmentally regulated RNA binding 
proteins during oogenesis  in Xenopus laevis. J. Biol. Chem. 258:4864-4869. 
Richter, J. D., and D.C. Evers.  1984.  A monoclonal antibody to an oocyte- 
specific poly(A) RNA-binding protein. J.  Biol.  Chem.  259:2190-2194. 
Richter, J. D., and L. D. Smith. 1984. Reversible inhibition of translation by 
Xenopus oocyte-specific  proteins. Nature (Lond.).  309:378-380. 
Richter, J. D., L. D. Smith, D. A. Anderson, and E. H. Davidson. 1984. Inter- 
spersed poly(A) RNAs of amphibian oocytes are not translatable. J. Mol. 
Biol.  173:227-241. 
Ruiz i Altaba, A., H. Perry-O'Keefe, and D. A. Melton.  1987. Xfin: an em- 
bryonic gene encoding a  multifingered protein in Xenopus. EMBO  (Fur. 
Mol.  Biol.  Organ.)J.  6:3065-3070. 
Sachs, A. B., M. W. Bond, and R. D. Kornberg.  1986.  A single gene from 
yeast for both nuclear and cytoplasmic polyadenylate-binding proteins. Do- 
main structure and expression. Cell.  45:827-835. 
Schmidt-Zachman, M. S., B. Hiigler-I~rr, and W. W. Franke. 1987. A consti- 
tutive nucleolar protein identified as a member of the nucleoplasmin family. 
EMBO (Fur. Mol.  Biol.  Organ.) J.  6:1881-1890. 
Shiokawa, K., Y.  Misumi, K. Tashiro, N.  Nakakura, K. Yamaha, and M. 
Ohuchida. 1989. Changes in the patterns of RNA synthesis in early embryo- 
genesis of Xenopus laevis. Cell. Differ.  28:17-26. 
Smith, S., and B. Stillman. 1989. Purification  and characterization of CAF-1, 
a human cell factor required for chromatin assembly  during DNA replication 
in vitro. Cell.  58:15-25. 
Spirin, A. S. 1966. On "masked" forms of messenger  RNA in early embryogen- 
esis and in other differentiating systems. Curr.  Top.  Dee. Biol.  1  : 1-38. 
Stick, R., and P. Hausen. 1985. Changes  in the nuclear lamina composition  dur- 
ing early development of Xenopus laevis. Cell.  41:191-200. 
Swiderski, R. E.,  and J.  D. Richter.  1988.  Photocrosslinking of proteins to 
maternal mRNA in Xenopus oocytes. Dee. Biol.  128:349-358. 
Ullrich, S. J., E. Appella, and W. E. Mercer. 1988. Growth related expression 
of a 72,000 molecular weight poly(A)  + mRNA binding protein. Exp.  Cell 
Res.  178:273-286. 
Wolin, S. L., G. Krohne, and M. W. Kirschner. 1987. A new lamin in Xenopus 
somatic tissues displays strong homology to human lamin A. EMBO (Fur. 
Mol.  Biol.  Organ.)J.  6:3809-3818. 
Woodland, H. R. 1974. Changes in the polysome content of developing Xeno- 
pus laevis embryos. Dee. Biol.  40:90-101. 
Woodland, H. R., J. M. Flynn, and A. J. Wyllie. 1979.  Utilization of stored 
mRNA in Xenopus embryos and its replacement by newly synthesized tran- 
scripts: Histone HI synthesis using interspecies hybrids. Cell.  18:165-171. 
Zelus, B. D., D. H. Giebelhaus, D. W. Eib, K. A. Kenner, and R. T. Moon. 
1989.  Expression of the poly(A)-binding protein during development of 
Xenopus laevis. Mol.  Cell.  Biol.  9:2756--2760. 
Murray et al. Soluble  mRNA Binding Proteins and Particles  11 